Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 11.41 M9.29 M9.24 M7.69 M8.39 M 34.61 M Research & development ————— — Operating income -8.16 M382 K1.07 M547 K242 K 2.25 M Non-Operating Income, Total ————— — Interest expense, net of interest capitalized 2.27 M2.38 M2.39 M2.18 M2.05 M 8.99 M Non-Operating Income, excl. Interest Expenses ————— — Unusual income/expense ————— — Pretax income -10.43 M-1.99 M-1.31 M-1.63 M-2.3 M -7.23 M Equity in earnings ————— — Taxes -22 K-22 K35 K25 K22 K 60 K Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations -10.41 M-1.97 M-1.35 M-1.66 M-2.32 M -7.29 M Discontinued operations ————— — Net income -10.41 M-1.97 M-1.35 M-1.66 M-2.32 M -7.29 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -10.41 M-1.97 M-1.35 M-1.66 M-2.32 M -7.29 M Basic earnings per share (Basic EPS) -0.5-0.09-0.06-0.08-0.11 -0.34 Diluted earnings per share (Diluted EPS) -0.5-0.09-0.06-0.08-0.11 -0.34 Average basic shares outstanding 20.86 M20.93 M21.03 M21 M21.2 M — Diluted shares outstanding 20.86 M20.93 M21.03 M21 M21.2 M — EBITDA -6.22 M2.13 M2.82 M6.05 M1.61 M 12.61 M EBIT -8.16 M382 K1.07 M547 K242 K 2.25 M Cost of revenue 57.5 M48.5 M51.87 M49.8 M52.07 M 202.24 M Other cost of goods sold ————— — Depreciation & amortization (cash flow) 1.94 M1.75 M1.75 M5.5 M1.37 M 10.36 M